Henkie Tan
Henkie Tan
Associate Professor
  • :412-965-3718

Department of Surgery
University of Pittsburgh Medical Center
USA

Education

Undergraduate

07/82 – 06/86 Loma Linda University, School of Allied Health
Loma Linda, CA 92515
BScMedical Technology

Graduate

08/86 – 06/94 Loma Linda University, School of Medicine
Medical Scientist Training Program (MSTP)
Loma Linda, CA 92515

PhD Microbiology/Immunology
MD  (under Dr Nehlsen-Cannarella,
former student of Nobel Laureate
Sir Peter Medawar)                                   

Postgraduate

07/94 – 06/99 Loma Linda University School of Medicine Brian Fandrich, MD
General Surgery Residency
07/99 – 06/01 Johns Hopkins University School of Medicine Andrew Klein, MD (chief, Transplant Surgery)
Multi-organ Transplant Surgery Fellowship

 

Biography

Dr. Tan performed the first purely laparoscopic live donor nephrectomy and developed the laparoscopic live donor nephrectomy program at UPMC where approximately 100 such operations are performed each year. He also performed the first dual kidney transplant at UPMC. Dr. Tan focuses on living donor kidney and liver transplantation and performs kidney, pancreas and liver transplants.

Dr. Tan received his combined M.D. and Ph.D. from the Medical Scientist Training Program at Loma Linda University. He received his Doctor of Philosophy in Microbiology/Immunology under the direction of Dr. Nelsen-Cannarella, a former student of Nobel Laureate Sir Peter Medawar. He completed his multi-organ transplant surgery fellowship at Johns Hopkins University School of Medicine.

Among Dr. Tan’s professional affiliations, he is a fellow of the American College of Surgeons, and a member of the American Society of Transplant Surgeons, American Society of Transplantation, the Transplantation Society, International Pediatric Transplantation Society, International Liver Transplantation Society, Central Surgical Association, Association for Academic Surgery and the Society of University Surgeons.

Dr. Tan served as the 2005-06 chair of the American Society of Transplantation Kidney and Pancreas Transplantation Committee and the 2005-07 co-chair and the 2007-08 chair of the Organ Donation Committee, among others. He has published widely in numerous transplant journals and books and is an editor of the textbook Living Donor Organ Transplantation: State of the Art. He has been nominated for America's Top Surgeons and Best Doctors in America.

Research Interest

  • Living Donor Organ Transplantation
  • live donor nephrectomy
  • kidney transplant
  • Pancreas Transplantation

 

Professional Activities:

Appointments And Positions

ACADEMIC
7/99 – 6/01
Johns Hopkins University School of Medicine
Baltimore, MD 21287
Instructor
Dept of Surgery
7/01 – 9/02 University of Rochester School of Medicine
Rochester, NY 15642
Assistant Professor of Surgery
Section of Organ Transplantation
10/02 – present University of Pittsburgh School of Medicine
Pittsburgh, PA 15213
Pittsburgh, PA 15213
Thomas E Starzl Transplant Institute
7/03 – 2011 University of Pittsburgh School of Medicine
Pittsburgh, PA 15213
Director,Living Donor Renal Transplantation
Thomas E Starzl Transplant Institute
12/10-2013 UPMC/STI Director, Transplant Surgery
Director, Transplant Surgery
6/11-2013 UPMC/STI Director, Pancreas Transplantation
11/14—present Veterans hospital of Pittsburgh Director, Kidney Transplantation

Honors

1983-1984 Honors Program, LLU/La Sierra Campus
6/85 Loma Linda Physicians Medical Group Research Award
  4/86 Tan HP, and Strong RM. Pancreatic adenocarcinoma: Diagnostic and treatment modalities. Poster Session, American Cancer Society Local Chapter. 4th Place.
3/87 Tan HP, Strong RM, and Chi JCH. Diagnostic and prognostic factors or
pancreatic adenocarcinoma: multi-variate regression analysis. Poster
Session, LLU Alumni Postgraduate Convention. 2nd Place.
1987 Walter E. Macpherson Award for “LLU School of Medicine Outstanding Student Researcher”
6/88 Roswell Park Memorial Institute Summer Oncology, Head and Neck
Surgery, Research fellowship and stipend
2/89 Redlands Community Hospital, Dept of Clinical Pathology, “Certification
of Appreciation” Award
5/90 NATO-Advance Science Institute on Molecular Basis of Human Cancer
competitive fellowship & the Norma Selma Travel Award. “Ettore
Majorana Center for Scientific Culture”, 11th course, Erice, Sicily, Italy.
1991 Walter E. Macpherson Award for “LLU School of Medicine Outstanding Student Researcher”
1992 National Dean’s List
1993 Medicine with Distinction Award: Honors Program in Medicine
1994 David B. Hinshaw “Excellence in Surgery” award as the top surgical medical student
5/96 Tri-County Surgical Society, 39th Annual. 1st Prize.
1998 “Outstanding Young Man of America” by Outstanding Young Americans
1998 International WHO’s WHO
2004 America’s Top Surgeons
2005 Best Doctors in America

 

Publications

  1. Tan HP, Nehlsen-Cannarella SL, Garberoglio CA, Tosk J. Recombinant IL-4 enhances the chemiluminescent oxidative burst of murine peritoneal macrophages. J Leukoc Biol 1991;49:587-591.
  2. Tan HP, Lebeck LK, Nehlsen-Cannarella SL. Regulatory role of cytokines in IgE-mediated allergy. J Leukoc Biol 1992;52:115-118.
  3. Tan HP, Smith J, Garberoglio CA. Pancreatic adenocarcinoma: An update. J Am Coll Surg 1996;183:164-184.
  4. Tan HP, Zamora J, Wahlstrom E, Hassanein T. Aureobasidium pneumonia in a post liver transplant recipient. Hepatogastroenterology 1997;44:1215-1218.
  5. Tan HP, Razzouk A, Gundry S, Bailey L. Pulmonary rhizopus rhizopodiformis cavitary abscess in a cardiac allograft recipient. J Cardiovas Surg 1999;40:223-226.
  6. Tan HP, Kavoussi LR, Sosa JA, Montgomery RA, Ratner LE. Laparoscopic live donor nephrectomy: Debating the benefits. Nephrol News Issues 1999;13:90-95.
  7. Tan HP, Markowitz JS, Maley WR, Merritt WT, Klein AS. Successful liver transplantation in a patient with Budd-Chiari syndrome caused by homozygous factor V Leiden. Liver Transpl 2000;6:654-656.
  8. Tan HP, Maley WR, Kavoussi LR, Montgomery RA, Ratner LE. Laparoscopic live donor nephrectomy: Evolution of a new standard. Curr Opin Organ Transplant 2000;12:312-318.
  9. Alfrey EJ, Lu AD, Carter JT, Bowers V, Taylor R, Ratner L, Cole E, Schweitzer E, Krishnamurthi V, Tan H, Stratta R. The dual kidney transplant registry. Transplant Proc 2001; 33:1099-1100.
  10. Nair S, Cohen DB, Cohen C, Tan H, Maley W, Thuluvath PJ. Postoperative morbidity, mortality, costs and long term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol 2001; 96:842-845.
  11. Tan HP, Dumler JS, Maley WR, Klein AS, Burdick, JF, Markowitz JS. Human monocytic ehrlichiosis: an emerging pathogen in transplantation. Transplantation 2001; 71: 1678-1680.
  12. Tan HP, Markowitz JS, Montgomery RA, Merrit WT, Klein AS, Thuluvath PJ, Poordad FF, Maley WR, Winters B, Akinci SB, Gaine SP. Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol. Liver Transpl 2001; 8: 745-749 (JCRIF 3.030).
  13. George P, Tan HP, Beebe H, Ratner LE. Successful renal transplantation after endovascular bifurcated stent graft repair of an abdominal aortic aneurysm. Transplantation 2001; 72: 533-535.
  14. Tan HP, Samaniego MD, Montgomery RA, Burdick JF, Maley WR, Kraus ES, Ratner LE. Donor horseshoe kidneys for transplantation. Transplantation 2001; 72: 869-873.
  15. Paik SW, Tan HP, Klein AS, Boitnott JK, Thuluvath PJ. Outcome after orthotopic liver transplantation in patients with hepatitis C. Dig Dis Sci 2002; 47: 450-5.
  16. Akinci SB, Gaine SP, Post W, Merrit WT, Tan HP, Winter B. Cardiac tamponade in an orthotopic liver recipient with pulmonary hypertension. Crit Care Med 2002; 30:699-701, 721-723.
  17. Tan HP, Orloff M, Marcos A, Mieles L, Kavoussi LR, Ratner LE. Laparoscopic live donor nephrectomy. Graft 2002; 5: 404-415.
  18. Tan, HP, Ratner LE. Gallstone ileus. Resident and Staff Physician 2002; 48: 10.
  19. Basu A, Tan HP, Shapiro R. Sirolimus. Curr Opin Organ Transplantation 2003; 8: 299-304.
  20. Tan HP, Basu A, Shapiro R. Everolimus: An update. Curr Opin Organ Transplantation 2003; 8: 323-326.
  21. Marcos A, Killackey M, Orloff MS, Mieles L, Bozorgzadeh A, Tan HP. Hepatic arterial reconstruction in 95 adult right lobe living donor transplants: Evolution of anastomotic technique. Liver Transpl 2003, 6:570-574.
  22. Galaria II, Marcos A, Orloff MS, Mieles L, Bozorgzadeh A, Kovach S, Tan HP. Pulmonary actinomycosis in solid organ transplantation. Transplantation 2003, 75: 1914-1915.
  23. Tan HP, Madeb R, Kovach SJ, Orloff M, Mieles L, Johnson LA, Bozorgzadeh A, and Marcos A. Hypophosphatemia after 95 right lobe living donor hepatectomy is not significant source of morbidity. Transplantation 2003, 76: 1085-1088.
  24. Shapiro R, Jordan ML, Basu A, Scantlebury V, Potdar S, Tan HP, Gray EA, Randhawa PS, Murase N, Zeevi A, Demetris AJ, Woodward J, Marcos A, Fung JJ, Starzl TE. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 2003, 238: 520-525; discussion 525-527.
  25. Tan HP, Marcos A. Hepatic arterial anatomy for right liver procurement from living donors. Liver Transpl 2004, 10: 134-135.
  26. Keven K, Basu A, Re L, Tan H, Marcos A, Fung JJ, Starzl TE, Simmons RL, Shapiro R. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transplant Infect Dis 2004, 6:10-14.
  27. Tan HP, Kaczorowski DJ, Basu A, Khan A, McCauley J, Marcos A, Fung JJ, Starzl TE, Shapiro R. Living-Related donor renal transplantation in HIV+ recipients using Alemtuzumab preconditioning and steroid-free Tacrolimus monotherapy: a single center preliminary experience. Transplantation 2004, 78: 1683-1688.
  28. Keven K, Basu A, Tan HP, Thai N, Khan AS, Marcos A, Starzl TE, Shapiro R. Cytomegalovirus prophylaxis using oral ganciclovir or valganciclovir in kidney and pancreas-kidney transplantation under antibody preconditioning. Transplant Proc. 2004; 36: 3107-3112.
  29. Tan HP, Marcos A. Hypophosphatemia and the live liver donor. Transplantation 2005, 79:258.
  30. Basu A, Ramkumar M, Tan HP, Khan A, McCauley J, Marcos A, Fung JJ, Starzl TE, Shapiro R. Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transplant Proc. 2005; 37: 923-926.
  31. Shapiro R, Basu A, Tan H, Gray E, Kahn A, Randhawa P, Murase N, Zeevi A, Girnita A, Metes D, Ness R, Bass DC, Demetris AJ, Fung JJ, Marcos A, Starzl TE. Kidney transplantation under minimal immunosuppression following pretransplant lymphoid depletion with thymoglobulin or campath. J Am Coll Surg 2005; 200:505-515.
  32. Tan HP, Marsh W, Marcos A. Liver Resection Using a Saline-Linked Radiofrequency Dissecting Sealer for Transection of the Liver. J Am Coll Surg 2005; 201:152.
  33. Tan HP, Patel-Tom K, Marcos A. Adult living donor liver transplantation: who is the ideal donor and recipient. J Hepatol 2005; 43: 13-17.
  34. Tan HP, Kaczorowski DJ, Basu A, McCauley J, Marcos A, Donaldson J, Unruh M, Randhawa P, Zeevi A, Shapiro R. Steroid-free tacrolimus monotherapy following pretransplant thymoglobulin or Campath and laparoscopy in living donor renal transplantation. Transpl Proc 2005; 37:4235-4240.
  35. Wu C, Evans I, Joseph R, Shapiro R, Tan H, Basu A, Smetanka C, Khan A, McCauley J, Unruh M. Comorbid conditions in kidney transplantation: association with graft and patient survival. J Am Soc Nephrol 2005; 16:3437-3444.
  36. Tan HP, Shapiro R, Montgomery RA, Ratner LE. Proposed live donor nephrectomy complication classification scheme. Transplantation 2006,81:1221-1223.
  37. Shapiro R, Ellis D, Tan HP, Moritz ML, Basu A, Vats AN, Khan AS, Gray EA, Zeevi A, McFeaters C, James G, Jo Grosso M, Marcos A, Starzl TE. Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr 2006; 148:813-8.
  38. Demetris AJ, Kelly DM, Eghtesad B, Fontes P, Wallis Marsh J, Tom K, Tan HP, Shaw-Stiffel T, Boig L, Novelli P, Planinsic R, Fung JJ, Marcos A. Pathophysiologic observations and histopathologic recognition of the portal hyper-perfusion or small-for-size syndrome. Am J Surg Pathol 2006; 30:986-993.
  39. Tan HP, Smaldone MC, Shapiro R. Immunosuppressive preconditioning or induction regimens: Evidence to date. Drugs 2006, 66: 1535-45.
  40. Tan HP, Kaczorowski DJ, Basu A, Unruh M, McCauley J, Wu C, Donaldson J, Dvorchik I, Kayler L, Marcos A, Starzl TE, Shapiro R. Living donor renal transplantation using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy. Am J Transplant, 2006, 6: 2409-2417.
  41. Thai NL, Khan A, Tom K, Blisard D, Basu A, Tan HP, et al. Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. Transplantation 2006, 82:1621-1624.
  42. Thai N, Blisard D, Tom K, Basu A, Smetanka C, Tan H, et al. Pancreas transplantation under Alemtuzumab (Campath-1H) and tacrolimus: correlation between low T cell responses and infection. Transplantation 2006, 82:1649-1652.
  43. Basu A, Falcone JL, Tan HP, et al. Chronic allograft nephropathy score before sirolimus rescue predicts allograft function in renal transplant patients. Transplant Proc 2007, 39:94-98.
  44. Kayler, LK, Blisard D, Basu A, Tan HP, et al. Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation 2007, 83:104-105.
  45. Tan HP, Shapiro R, Tom K, et al. Outcome of alemtuzumab pre-conditioning and tacrolimus monotherapy in living donor liver and kidney transplantation. Expert Rev Pharmacoeconomics Outcomes Res 2007, 7(2):1-6.
  46. Silveira FP, Husain S, Kwak EJ, Linden PK, Marcos A, Shapiro R, Fontes P, Marsh JW, de Vera M, Tom K, Thai N, Tan HP, et al. Cryptococcosis in liver and kidney transplant recipients receiving thymoglobulin or alemtuzumab. Transplant Infect Dis 2007, 9:22-27.
  47. Tan HP, Vyas D, Basu A, et al. Cold heparinized lactated ringers with procaine (HeLP) preservation fluid in 266 living donor kidney transplantations. Transplantation 2007, 83: 1134-1136.
  48. Kayler LK, Lakkis FG, Morgan C, Basu A, Blisard D, Tan HP, et al. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion. Am J Transplant 2007, 7:949-954.
  49. Ellis D, Shapiro R, Moritz M, Vats A, Basu A, Tan H, et al. Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. Transplantation 2007, 83:1563-1570.
  50. Shapiro R, Ellis D, Tan HP, et al. Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation. Am J Transplant 2007, 7:2736-2738.
  51. Wu S, Shapiro R, Tan H, et al. Kidney transplantation in the elderly: the influence of recipient comorbidity and living kidney donors. J Am Geriatr Soc 2008, 56:231-238.
  52. Bartynski WS, Tan HP, Boardman JF, et al. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008, May; 29(5):924-30.
  53. Batal I, Zeevi A, Heider A, Girnita A, Basu A, Tan H, et al. Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation. Am J Clin Pathol 2008, 129:587-591.
  54. Shapiro R, Zeevi A, Basu A, Tan HP, et al. Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation 2008, 85(8):1125-32.
  55. Batal I, Girnita A, Zeevi A, Saab BA, Stockhausen S, Shapiro R, Basu A, Tan H, et al. Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney. Mod Pathol 2008, 21:1490-8.
  56. Tan HP, Donaldson J, Ellis D, et al. Pediatric living donor kidney transplantation under Alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. Transplantation 2008, 86:1725-31.
  57. Shapiro R, Basu A, Tan HP, et al. Kidney after extrarenal transplantation—The impact of alemtuzumab induction. Transplantation 2008May; 8(Suppl 2): 439.
  58. Horbinski C, Bartynski WS, Carson-Walter E, Hamilton RL, Tan HP, et al. Reversible encephalopathy after cardiac transplantation: Histologic evidence of endothelial activation, T-cell specific trafficking, and VEGF expression. AJNR Am J Neuroradiol 2009; 30:588-90.
  59. Tan HP, Donaldson J, Basu A, et al. 200 living donor kidney transplantations under Alemtuzumab induction and tacrolimus monotherapy: 3 year follow up. Am J Transplant 2009; 9:355-66.
  60. Shapiro R, Basu A, Tan HP, et al. Kidney after nonrenal transplantation-the impact of alemtuzumab induction. Transplantation. 2009; 88:799-802.
  61. Gupta G, Shapiro R, Girnita A, Batal I, McCauley J, Basu A, Tan H, et al. Neutrophilic tubulitis as a marker for urinary tract infection in renal allograft biopsies with C4d deposition. Transplantation. 2009; 87:1013-8.
  62. Batal I, Zainah H, Stockhausen S, Basu A, Tan H, et al. The significance of renal C4d staining in patients with BK viruria, viremia, and nephropathy. Mod Pathol 2009; 1-9.
  63. Batal I, Franco ZM, Shapiro R, Basu A, Tan H, et al. Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunction. Hum Pathol. 2009; 40:1312-9.
  64. Shapiro R, Basu A, Zeevi A, Lunz J, Mapara M, Randhawa P, Morgan C, Tan HP, et al. Bortezomib rescue in refractory acute humoral rejection--report of a case. Clin Transpl. 2009:431-2.
  65. Younas N, Wu CM, Shapiro R, McCauley J, Johnston J, Tan H, et al. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival. BMC Nephrol 2010; 11:5.
  66. Trivedi H, Tan HP, et al. Colonic perforation by a dormant peritoneal dialysis catheter postrenal transplantation. Am Surg 2010; 76:908-9.
  67. Abrams P, Humar A, Tan HP. Role of Tacrolimus Prolonged Release in the Prevention of Transplant Rejection. Transplant Research and Risk Management. 2010 Aug; 2: 65-70.
  68. Batal I, Lunz JG 3rd, Aggarwal N, Zeevi A, Sasatomi E, Basu A, Tan H, et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant. 2010 Nov;10(11):2442-52.
  69. Shapiro R, Lunz J, Zeevi A, Basu A, Mapara M, Randhawa P, Tan HP, Sharma V, Humar A. 1.7 year follow-up after bortezomid therapy for refractory antibody mediated rejection. Clin Transpl. 2010: 405-7.
  70. Younas N, Wu CM, Shapiro R, McCauley J, Johnston J, Tan H, et al. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival. BMC Nephrol. 2010 Apr 1;11:5.
  71. Ashokkumar C, Shapiro R, Tan H, et al. Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation. Transplantation 2011 Aug 27;92(4):433-8.
  72. Shapiro R, Sturdevant M, Lopez R, Tan H, Basu A, Wijkstrom M, Humar A. Kidney transplantation at the University of Pittsburgh. Clin Transpl 2011:67-76.
  73. Basu A, Falcone J, Dvorchik I, Tan H, et al. Outcomes of renal transplantation in recipients with peak panel reactive antibody >30% under tacrolimus-based immunosuppression. Ann Transplant 2011 Sep 30; 16(3):5-13.
  74. Batal I, Azzi J, El-Haddad n, Riella LV, Lunz JG 3rd, Zeevi A, Sasatomi E, Basu A, Tan H, et al. Immunohistochemical markers of tissue injury in biopsies with transplant glomerulitis. Hum Pathol 2012 Jan; 43(1):69-80.
  75. Macedo C, Walters JT, Orkis EA, Isse K, Elinoff BD, Fedorek SP, McMichael JM, Chalasani G, Randhawa P, Demetris AK, Zeevi A, Tan H, et al. Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation. Transplantation 2012, 93(8):813-21.
  76. Masutani K, Shapiro R, Basu A, Tan H. The Banff 2009 working proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome. Am J Transpl 03/2012, 12(4):907-18-49.
  77. Steel J, Dunlavy A, Friday M, Kingsley K, Brower D, Unruh M, Tan H. A national survey of independent living donor advocates: the need for practice guidelines. Am J of Tranpl, 05/2012, 12(8):2141-9.
  78. Myaskovsky L, Doebler DA, Posluszny DM, Dew MA, Unruh M, Crowley-Matoka M, Switzer GE, Chang C-CH, DiMartini AF, Shapiro R, and Tan H. Rates and correlates of health maintenance behaviors after living kidney donation. Progress in Transplantation, 2012 Jun, 22(2):147-154.
  79. Dew MA, Zuckoff A, DiMartini AAF, DeVito Dabbs AJ, McNulty ML, Fox KR, Switzer GE, Humar A, and Tan H. Prevention of Poor Psychosocial Outcomes in Living Organ Donors: From Description to Theory-Driven Intervention Development and Initial Feasibility Testing. Progress in Transplantation, 2012 Sep; 22:280-292.
  80. Masutani K, Shapiro R, Basu A, Tan H, Ninomiya T, Randhawa P. Putative episodes of T-cell-mediated rejection in patients with sustained BK viruria but no viremia. Transplantation 2012, 94(1):43-49.
  81. Puttarajappa C, Shapiro R, and Tan HP. Antibody-mediated rejection in kidney transplantation: A review. J Transplant, 2012;2012:193724.
  82. Steel J, Dunlavy A, Friday M, Kingsley K, Brower D, Unruh M, Tan H. The development of practice guidelines for independent living donor advocates. Clinical Transpl, 03/2013, 27(2):178-84.
  83. Dew MA, DiMartini AAF, DeVito Dabbs AJ, Zuckoff A, Tan H. Preventive intervention for living donor psychosocial outcomes: feasibility and efficacy in a randomized controlled trial. Am J of Tranpl, 08/2013.

 

transplantation-research Journal Flyer